Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06033391
Other study ID # 2557724
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 9, 2024
Est. completion date May 24, 2024

Study information

Verified date June 2024
Source University of Valencia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the present study is to assess the efficacy of the module GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents) in reducing obsessive-compulsive disorder (OCD) related maladaptive beliefs and OCD symptoms in adolescents from 15 to 18 years old. Specifically, a randomized controlled trial with two conditions (experimental and control) will be carried out in a non-clinical adolescent population to assess pre-post-intervention changes. After 14 days of using GGOC-AD, it is expected, primarily, to find a decrease in OCD-related maladaptive beliefs and OCD symptoms. As secondary results, we do not expect changes in emotional symptomatology, but we do expect an increase in self-esteem. Additionally, these changes are expected to be found in a one-month follow-up.


Description:

Pediatric OCD is a serious problem and, if not treated early on, is associated with significant impairment. The app GGOC, aimed at working on OCD-related dysfunctional beliefs in adults, has proven in previous studies in adult clinical and non-clinical samples, to significantly decrease maladaptive beliefs associated with OCD and obsessive-compulsive symptomatology. Also, it can significantly increase self-esteem. Therefore, it is relevant to adapt the GGOC application to the adolescent population (GGOC-AD) and evaluate its effectiveness.


Recruitment information / eligibility

Status Completed
Enrollment 94
Est. completion date May 24, 2024
Est. primary completion date May 24, 2024
Accepts healthy volunteers No
Gender All
Age group 15 Years to 17 Years
Eligibility Inclusion Criteria: 1. To have signed the informed consent, both the adolescents and their parents or legal guardians. 2. Being enrolled in 4th level of Obligatory Secondary Education of the Spanish Education System (ISCED levels 2 and 3 in the International Standard Classification of Education) 3. To have a mobile phone (indistinctly Android or iOS mobile system) with Internet access.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
GGOC-AD (GG Obsessive-Compulsive Disorder - Adolescents)
GGOC was originally designed to challenge maladaptive beliefs that underline OCD symptoms in adult population. It was adapted to adolescent population. It consists of statements that are presented to the user, and that can portray either negative ("I can't trust myself") or positive beliefs ("I have a lot of good characteristics"). Users have to respond by either pulling these towards "Accept" or "Reject".
GGN-AD (GG Neutral - Adolescents)
it was designed to have a comparison group. It consists of neutral statements such as "Madrid is a Spanish city", that ought not to produce changes in the direction of our hypothesis. These have to be "Accepted" or "Rejected" based on their veracity.

Locations

Country Name City State
Spain University of Valencia/ Universitat de València Valencia

Sponsors (2)

Lead Sponsor Collaborator
University of Valencia Ministry of Science and Innovation

Country where clinical trial is conducted

Spain, 

References & Publications (1)

Roncero M, Belloch A, Doron G. Can Brief, Daily Training Using a Mobile App Help Change Maladaptive Beliefs? Crossover Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Feb 13;7(2):e11443. doi: 10.2196/11443. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in obsessive beliefs Score change in obsessive compulsive maladaptive beliefs measured by the Obsessive Beliefs Questionnaire-Child Version (OBQ-CV). Total score is computed as a mean of the 44 items, ranging from 0 "strongly disagree" to 4 "strongly agree". Higher scores indicate the person has more obsessive beliefs. Through app completion (14 days) and 1 month follow-up
Primary Change in obsessive-compulsive symptomatology Score change in obsessive-compulsive symptoms measured by the Obsessive Compulsive Inventory- Child Version (OCI-R-CV). Total score is computed as a mean of the 21 items, ranging from 0 "never" to 2 "always". Higher scores indicate a greater presence of obsessive-compulsive symptoms. Through app completion (14 days) and 1 month follow-up
Secondary Change in emotional symptoms Change in depression and anxiety symptoms measured by The Patient Health Questionnaire for Depression and Anxiety (PH-4). It consists of 4 items, two for Anxiety and two for Depression, with a 4-point Likert scale (from 0 = "never" to 3 = "almost every day"). Higher scores indicate a greater presence of depression or anxiety symptoms. Through app completion (14 days) and 1 month follow-up
Secondary Change in self-esteem Change in score of Single Item Self Esteem Scale (SISE). Self-Esteem is measured with this single item ranging from 1 "It is not very true for me" to 7 "It is very true for me". Higher scores indicate a higher self-esteem. Through app completion (14 days) and 1 month follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT05967468 - Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder N/A
Recruiting NCT05609916 - CBT Augmentation to Promote Medication Discontinuation in Pediatric OCD N/A
Recruiting NCT06356090 - SPACE: a Parent-based Treatment for Pediatric OCD N/A
Not yet recruiting NCT05547334 - IBA Treatment in Adolescents With OCD N/A
Completed NCT04922502 - Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder Phase 2/Phase 3
Recruiting NCT06152913 - HANDS-ON: a Personalized, Brief and Intensive Exposure-based Intervention for Youth With Persistent Anxiety or OCD N/A
Active, not recruiting NCT03595098 - Treatment Effects of Family Based Cognitive Therapy in Children and Adolescents With Obsessive Compulsive Disorder N/A